0000912282-23-000579.txt : 20231220 0000912282-23-000579.hdr.sgml : 20231220 20231220175810 ACCESSION NUMBER: 0000912282-23-000579 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231212 FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VITA NICHOLAS CENTRAL INDEX KEY: 0001907623 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-56294 FILM NUMBER: 231502379 MAIL ADDRESS: STREET 1: C/O COLUMBIA CARE INC. STREET 2: 680 FIFTH AVENUE, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cannabist Co Holdings Inc. CENTRAL INDEX KEY: 0001776738 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 981488978 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 680 FIFTH AVENUE, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125543424 MAIL ADDRESS: STREET 1: 680 FIFTH AVENUE, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Columbia Care Inc. DATE OF NAME CHANGE: 20190514 4 1 form4.xml X0508 4 2023-12-12 0001776738 Cannabist Co Holdings Inc. CBSTF 0001907623 VITA NICHOLAS C/O THE CANNABIST COMPANY HOLDINGS INC. 680 FIFTH AVENUE, 24TH FLOOR NEW YORK NY 10019 true true Chief Executive Officer false Common Shares 2023-12-12 4 S 0 200000 0.375 D 19827075 I Held by Vita Holdings LLC Common Shares 2023-12-18 4 S 0 100000 0.396 D 19727075 I Held by Vita Holdings LLC Common Shares 618950 D The sales price reported above was converted from the Canadian sales price of $0.51 using an exchange rate of C$1.3599 = US$1.00. The sale price reported above was converted from the Canadian sale price of C$0.53 using an exchange rate of C$1.3387 = US$1.00. Shares sold by third-party financial institution in partial satisfaction of debt obligation. Funding was primarily used for pediatric medical research for orphan and ultra rare illnesses, tax payments, education and philanthropic purposes. /s/ Nicholas Vita 2023-12-20